Indian University Technology Database

Life Sciences

New Anti-tubercular Drugs
Ref No:KCRB01/017
Sub Class: Pharmaceutical and Healthcare
Technology Outcome: Product
Development Status: Preliminary Research
IPR Status: Not Patented
Technology Description: The drug design is based on specific inhibition of proteins/enzymes, which are crucial in the survival, and virulence of mycobacteria. Small molecular weight ligands secreted by mycobacteria for absorption of metal from surroundings is used as carrier vectors for delivering the anti-bacterial drugs intracellularly, resulting in selective and effective antibacterial activities. The application area for this product is drug discovery program of pharmaceutical industry. The competitive advantages are: (i) Selective toxicity (ii) Enhanced activity (iii) Overcoming drug resistance problem.
Technology owner: Private Individual
Suggested transfer means: Joint research, Joint Commercialization
Type of technology partner sought: Pharma industries with R & D and pilot plant facility for manufacturing pharmaceutical grade drugs for clinical trials.oans.com
Geographical areas where partners are sought: Worldwide, Europe, North America
Source: University of Pune